Martin J. Gilligan
Corporate Officer/Principal en PHATHOM PHARMACEUTICALS, INC. .
Perfil
Martin J.
Gilligan is currently the Chief Commercial Officer at Phathom Pharmaceuticals, Inc. Previously, he worked as the VP-Inflammation & Immunology at Celgene Corp.
He holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Providence College.
Cargos activos de Martin J. Gilligan
| Empresas | Cargo | Inicio |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06/01/2020 |
Antiguos cargos conocidos de Martin J. Gilligan.
| Empresas | Cargo | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Formación de Martin J. Gilligan.
| Rutgers State University of New Jersey | Masters Business Admin |
| Providence College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Martin J. Gilligan
